Streetbeat News

Earnings

XHR

Xenia Hotels & Resorts (NYSE:XHR) reported its Q4 AFFO per share as $0.41, consistent with the previous year. However, its quarterly sales of $253.38M fell short of the analyst consensus estimate of $253.79M by 0.16% and marked a 3.71% decrease from the $263.14M reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:32 am

AESI

Atlas Energy Solutions (AESI) reported Q4 2023 earnings of $0.36 per share, missing the consensus estimate of $0.59 by 38.98%. Quarterly sales were $141.14M, missing the estimate of $145.77M by 3.18%, and representing a 5.82% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:32 am

CLDT

Chatham Lodging (NYSE:CLDT) reported Q4 AFFO per share of $0.19, surpassing the $0.15 estimate, and sales of $72.28M, exceeding the $70.69M estimate. This represents a 5% decrease in AFFO per share year-over-year but a 2.78% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:31 am

DEA

Easterly Government Properties (DEA) reported Q4 FFO of $0.28 per share, meeting consensus estimates but marking a 3.45% decrease from the previous year. Sales of $72.62M missed estimates by 1.33% and decreased 1.21% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:31 am

HSIC

Henry Schein's shares dropped following a report of disappointing Q4 FY2023 earnings and weaker than expected guidance for 2024.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:25 am

AESI

Atlas will include Hi-Crush's financial results in its reports starting March 1, 2024, expecting sand prices to average $26-$28 per ton. With Hi-Crush's contribution, Atlas forecasts 2024 Adjusted EBITDA between $425-$475 million and capex of $335-$360 million.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:21 am

CLVT

Clarivate projects its 2024 revenues to be between $2.57B and $2.67B, below the consensus of $2.69B, and adjusted diluted EPS to range from $0.70 to $0.80, under the consensus of $0.84. The company anticipates organic growth, offset by soft transactional revenue and a small divestiture in the IP segment. Despite topline growth, investments and cost inflation are expected to contract profit margins. Capital spending will increase to about 10% of revenues for product innovation, with strong cash flow aimed at reducing debt.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:18 am

PRVA

Privia Health Group (PRVA) projects its FY24 revenue to be between $1.600B and $1.675B, significantly below the estimated $3.24B. The company plans to focus on organic provider growth, renegotiate Medicare Advantage arrangements, and exit the Delaware ACO to improve margins and increase free cash flow. Despite a projected decrease in practice collections due to these changes, PRVA expects an increase in care margin, platform contribution, and Adjusted EBITDA.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:17 am

CRI

Carter's, Inc. (CRI) forecasts low single-digit growth in net sales reaching around $3B for FY24, slightly above the $2.98B estimate. The company also anticipates mid-single-digit growth in adjusted diluted EPS.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:17 am

CRI

Carter's Q4 adjusted EPS of $2.76 exceeded the $2.63 estimate, a 20.52% increase YOY. However, sales of $857.86M fell short of the $869.05M estimate, marking a 5.95% decrease YOY.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:14 am